Though there have been reports earlier in animal studies about the safety and efficacy of (Ref.1-3) different biomaterials as scaffolds implanted into the site of neuronal damage, this is the first time that has been applied in a canine with miraculous outcome.
The reports have confirmed that the MAP2 and NeuN marker positive neuronal precursors are observed in vivo for a longer time than when implanted without the scaffolds
(1).
When the stem cells are implanted with scaffolds, they produce more such stem cells/precursors with relatively more growth factors and neuronal cells yielding better outcome which has proven itself to be effective to this miraculous recovery of Rambo.
Thanks to the team of clinicians of TANUVAS who compassionately treated Rambo and the scientists of NCRM who with their state-of-the-art cutting edge technology using nano biomaterials have expanded the stem cells of Rambo in the lab.
This study was funded by M/S Hope Foundation (Trust) Chennai, India.
Stem cell therapy is undertaken as an experimental therapy and for human applications it is governed by the guidelines issues by ICMR( Click to read )
This was done as a joint work between TANUVAS and NCRM following a MoU signed (click to read) & the earlier data of the study when started were presented in the annual symposium at NCRM NICHE in October 2009 (click to read)
Reference
1. Osanai T, Kuroda S, Yasuda H, Chiba Y, Maruichi K, Hokari M, Sugiyama T,
Shichinohe H, Iwasaki Y.
"Noninvasive transplantation of bone marrow stromal cells
for ischemic stroke: preliminary study with a thermoreversible gelation polymer
hydrogel". Neurosurgery. 2010 Jun